All CIRM Grants

Institution Researcher name Grant Type Grant Title Award Value
Stanford University James Dunn Tools and Technologies III Skin-derived precursor cells for the treatment of enteric neuromuscular dysfunction $772,098
University of California, Los Angeles Carla Koehler Tools and Technologies III A small molecule tool for reducing the malignant potential in reprogramming human iPSCs and ESCs $1,283,900
University of California, San Diego Shyni Varghese Tools and Technologies III Technologies to improve in vivo function of transplanted stem cells $1,373,683
Scripps Research Institute Jeanne Loring Tools and Technologies III User-friendly predictive molecular diagnostic assays for quality control of stem cell derivatives for transplantation and drug discovery $1,728,390
University of California, Los Angeles Leif Havton Tools and Technologies III Development of a Relevant Pre-Clinical Animal Model as a Tool to Evaluate Human Stem Cell-Derived Replacement Therapies for Motor Neuron Injuries and Degenerative Diseases $1,308,711
University of California, Los Angeles James Dunn Tools and Technologies III Skin-derived precursor cells for the treatment of enteric neuromuscular dysfunction $1,044,423
University of California, Davis J. Leach Tools and Technologies III Multi-modal technology for non-destructive characterization of bioengineered tissues $1,574,151
University of California, Davis Laura Marcu Tools and Technologies III Multimodal platform combining optical and ultrasonic technologies for in vivo nondestructive evaluation of engineered vascular tissue constructs $1,834,350
Gordon Research Conferences Leonard Zon Conference 2015 Gordon Research Conference: Stem Cells & Cancer $20,000
City of Hope, Beckman Research Institute Fouad Kandeel Conference 15th Annual Rachmiel Levine Diabetes and Obesity Symposium $20,000
Gladstone Institutes, J. David Steven Finkbeiner Conference THE 5TH ANNUAL CALIFORNIA ALS PAC10 AND RESEARCH NETWORK MEETING $9,529
University of California, San Diego Catriona Jamieson Alpha Stem Cell Clinics Alpha Stem Cell Clinic for the Development of Regenerative Therapies $8,679,137
University of California, Los Angeles John Adams Alpha Stem Cell Clinics UCLA-UCI Alpha Stem Cell Clinic (ASCC) Consortium $8,680,000
City of Hope, Beckman Research Institute John Zaia Alpha Stem Cell Clinics The Innovation-Alpha Clinic for Cellular Therapies (I-ACT) – A Program for the Development and Delivery of Innovative Cell-based Treatments and Cures for Life-threatening Diseases. $8,456,000
University of California, Davis Alice Tarantal Conference 13th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases $10,000
ViaCyte, Inc. Howard Foyt Accelerated Development Pathway I Clinical Development of a Cell Therapy for Diabetes $8,783,852
Sanford Consortium for Regenerative Medicine Edward Holmes Conference Stem Cell Meeting on the Mesa $40,000
University of California, San Francisco Susan Fisher Conference The Stem Cell Niche in Development and Disease $5,000
University of California, San Francisco Diana Laird Conference The 2014 Santa Cruz Developmental Biology Meeting $3,000
Lineage Cell Therapeutics, Inc. Francois Binette Strategic Partnership III Track A A Phase I/IIa Dose Escalation Safety Study of AST-OPC1 in Patients with Cervical Sensorimotor Complete Spinal Cord Injury $14,323,318
City of Hope, Beckman Research Institute John Zaia Strategic Partnership III Track A A Phase I, Open-Label Study To Assess The Safety, Feasibility and Engraftment of Zinc Finger Nucleases (ZFN) CCR5 Modified Autologous CD34+ Hematopoietic Stem/Progenitor Cells (SB-728MR-HSPC) with Escalating Doses of Busulfan In HIV-1 (R5) Infected Sub... $5,583,438
University of California, Berkeley Xavier Darzacq Research Leadership Single Molecule Biophysics and Biology of Cellular Identity $4,175,924
Gladstone Institutes, J. David Todd McDevitt Research Leadership Engineering microscale tissue constructs from human pluripotent stem cells $5,849,100
University of California, Los Angeles John Chute Research Leadership Niche-Focused Research: Discovery & Development of Hematopoietic Regenerative Factors $4,645,297
University of California, Irvine Michelle Khine Conference UC Systemwide Bioengineering Symposium $7,525
Stanford University Fan Yang Conference 2014 Materials Research Society (MRS) Spring Meeting: Symposium Y: Biomaterials for Biomolecule Delivery and Understanding Cell-Niche Interactions $10,000
University of California, San Francisco Tippi MacKenzie Conference In Utero Hematopoietic Stem Cell Transplantation and Maternal-Fetal Tolerance $17,526
Biocom Institute Jennifer Landress Conference The 2014 BIO International Convention $50,000
University of California, San Diego Christian Metallo Basic Biology V Metabolic regulation of cardiac differentiation and maturation $1,124,834
Cedars-Sinai Medical Center Paul Noble Basic Biology V Innate Immune Regulation of Lung Alveolar Stem Cell Renewal in Mouse and Man $617,662
University of California, Los Angeles Samantha Butler Basic Biology V Assessing the mechanism by which the Bone Morphogenetic Proteins direct stem cell fate $515,730
University of California, San Diego Cornelis Murre Basic Biology V Epigenetic mechanisms that enforce pluripotency in embryonic stem cells $1,160,997
University of California, San Diego Lawrence Goldstein Basic Biology V Elucidating pathways from hereditary Alzheimer mutations to pathological tau phenotypes $1,050,300
University of California, San Francisco Mark Anderson Basic Biology V Generation of a functional thymus to induce immune tolerance to stem cell derivatives $1,191,000
Palo Alto Veterans Institute for Research Thomas Rando Basic Biology V Molecular regulation of stem cell potency $966,510
Stanford University Helen Blau Basic Biology V Mass Cytometry to Delineate the Human Muscle Stem Cell Hierarchy and Dysfunction in Aging $1,175,357
University of California, Merced Kara McCloskey Basic Biology V Directed Differentiation of Specialized Endothelial Cells $475,686
Salk Institute for Biological Studies Ronald Evans Basic Biology V Metabolically-driven epigenetic changes in iPSC reprogramming $1,491,900
Gladstone Institutes, J. David Sheng Ding Basic Biology V A novel druggable mechanism to safeguard stem cell genome $1,294,495
University of California, Los Angeles Bennett Novitch Basic Biology V In vitro modeling of human motor neuron disease $1,147,114
University of California, San Diego Dianne McKay Basic Biology V Role of intracytoplasmic pattern recognition receptors in HSC engraftment $615,639
Stanford University Michael Snyder Genomics Centers of Excellence Awards (R) Center of Excellence for Stem Cell Genomics - Stanford $22,787,914
University of California, San Francisco Valerie Weaver Basic Biology V Biophysical Determinants of Early Embryonic Stem Cell Fate Specification $1,186,500
University of California, Irvine Peter Donovan Basic Biology V Non-invasive live imaging of stem cell signature metabolic states $516,366
Salk Institute for Biological Studies Joseph Ecker Genomics Centers of Excellence Awards (R) Center of Excellence for Stem Cell Genomics - Salk $13,201,635
University of California, San Diego David Cheresh Basic Biology V CD61-driven stemness program in epithelial cancer $1,161,000
University of California, Santa Cruz Joshua Stuart Genomics Centers of Excellence Awards (R) Center of Excellence for Stem Cell Genomics - UCSC $3,999,083
University of California, Berkeley Andrew Dillin Basic Biology V A Requirement for Protein Homeostasis in the Mediation of Stem Cell Health $1,034,100
University of Southern California Denis Evseenko Basic Biology V Promoting survival and countering hypertrophy of pluripotent stem cell (PSC)-derived chondrocytes $735,138
University of California, San Diego Miles Wilkinson Basic Biology V New Regulators of Spermatogonial Stem Cells: RHOX Homeobox Transcription Factors $552,811
University of California, San Diego Maike Sander Basic Biology V Defining links between chromatin state and developmental competence $1,050,300
University of California, San Diego Wei Wang Basic Biology V Systems-level discovery of the regulatory mechanisms directing differentiation of hESC $1,161,000
Stanford University Marius Wernig Basic Biology V Mechanisms of human induced neuronal cell reprogramming $1,178,370
Stanford University Xinnan Wang Basic Biology V Misregulated Mitophagy in Parkinsonian Neurodegeneration $1,174,943
Stanford University Gary Steinberg Basic Biology V Paracrine and synaptic mechanisms underlying neural stem cell-mediated stroke recovery $1,178,370
California Institute of Technology David Tirrell Basic Biology V Engineered matrices for control of lineage commitment in human pancreatic stem cells $526,896
University of California, Los Angeles Lili Yang Basic Biology V Differentiation of Human Hematopoietic Stem Cells into iNKT Cells $614,400
University of California, Irvine Lisa Flanagan Basic Biology V Molecular basis of plasma membrane characteristics reflecting stem cell fate potential $994,108
University of California, Los Angeles Denis Evseenko Basic Biology V Promoting survival and countering hypertrophy of pluripotent stem cell (PSC)-derived chondrocytes $411,330
University of California, San Francisco Jason Rock Conference Tri-Institutional Stem Cell Retreat $3,500
Stanford University Thomas Rando Conference Third Annual Symposium on Regenerative Rehabilitation $20,000
Human Organ Project Anita Caufield Conference Regenerative Medicine Foundation 2014 Conference $50,000
Stanford University Joseph Wu Conference Cardiovascular Regenerative Medicine Symposium $9,000
University of California, San Diego Thomas Kipps Disease Team Therapy Development III Therapeutic Eradication of Cancer Stem Cells with UC-961 (Cirmtuzumab) $4,179,598
Stanford University Irving Weissman Disease Team Therapy Development III Clinical Investigation of a Humanized Anti-CD47 Antibody in Targeting Cancer Stem Cells in Hematologic Malignancies and Solid Tumors $6,505,568
University of California, Los Angeles Donald Kohn Disease Team Therapy Development III Clinical Trial of Stem Cell Gene Therapy for Sickle Cell Disease $13,145,465
University of California, Davis Peter Belafsky Disease Team Therapy Development III Tissue Engineered Recellularized Laryngotracheal Implants $3,181,162
University of Southern California Mark Humayun Disease Team Therapy Development III Phase 1 Safety Assessment of CPCB-RPE1, hESC-derived RPE Cell Coated Parylene Membrane Implants, in Patients with Advanced Dry Age Related Macular Degeneration $16,339,827
University of California, Los Angeles Dennis Slamon Disease Team Therapy Development III A Phase I dose escalation and expansion clinical trial of the novel first-in-class Polo-like Kinase 4 (PLK4) inhibitor, CFI-400945 in patients with advanced solid tumors $5,683,693
Gladstone Institutes, J. David Deepak Srivastava Conference Keystone Symposia, "Stem Cells and Reprogramming" $50,000
University of California, Davis Mark Yarborough Conference Stem Cell Research for Neurological Disorders: A Case Study in Ethical and Policy Issues in ALS Research $1,020
University of California, San Francisco Jeffrey Rosenfeld Conference California ALS Research Summit 2014 $8,563
Alliance Forum Foundation George Hara Conference 2013 World Alliance Forum in San Francisco $3,500
University of California, Los Angeles Dana Jones Conference 7th CA/HSCI Junior PI Conference: Stem Cells 2.0 $2,500
Sanford Consortium for Regenerative Medicine Edward Holmes Conference The Sanford Consortium for Regenerative Medicine's Scientific Symposium and the Regen Med Partnering Forum at Stem Cell Meeting on the Mesa VIII $35,000
University of California, San Francisco Regis Kelly Conference The Science of Staying Younger Longer $6,500
University of California, Davis Alice Tarantal Conference 12th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases $8,000
Scripps Research Institute Jeanne Loring Conference World Stem Cell Summit $30,000
Numerate, Inc. John Griffin Early Translational IV Use of human iPSC-derived neurons from Huntington’s Disease patients to develop novel, disease-modifying small molecule structural corrector drug candidates targeting the unique, neurotoxic conformation of mutant huntingtin $520,015
Sanford Burnham Prebys Medical Discovery Institute Stuart Lipton Early Translational IV Programming Human ESC-derived Neural Stem Cells with MEF2C for Transplantation in Stroke $1,020,815
Stanford University Michele Calos Early Translational IV Engineered iPSC for therapy of limb girdle muscular dystrophy type 2B $1,876,253
University of California, Los Angeles Robert Reiter Early Translational IV Clinical Development of an N-cadherin Antibody to Target Cancer Stem Cells $4,075,668
The Scintillon Institute Stuart Lipton Early Translational IV Programming Human ESC-derived Neural Stem Cells with MEF2C for Transplantation in Stroke $1,103,185
University of California, Los Angeles Zack Jerome Early Translational IV Stem Cell Programming With Chimeric Antigen Receptors to Eradicate HIV Infection $4,925,166
University of California, Irvine Magdalene Seiler Early Translational IV Restoring vision by sheet transplants of retinal progenitors and retinal pigment epithelium (RPE) derived from human embryonic stem cells (hESCs) $3,998,948
University of California, Los Angeles Donald Kohn Early Translational IV Beta-Globin Gene Correction of Sickle Cell Disease in Hematopoietic Stem Cells $1,651,884
Salk Institute for Biological Studies Inder Verma Early Translational IV Development of a cell and gene based therapy for hemophilia $2,298,634
Human BioMolecular Research Institute John Cashman Early Translational IV Improving Existing Drugs for Long QT Syndrome type 3 (LQT3) by hiPSC Disease-in-Dish Model $6,361,369
University of California, Los Angeles Gerald Lipshutz Early Translational IV Gene therapy-corrected autologous hepatocyte-like cells from induced pluripotent stem cells for the treatment of pediatric single enzyme disorders $1,801,629
Cedars-Sinai Medical Center Dan Gazit Early Translational IV Gene Targeting to Endogenous Stem Cells for Segmental Bone Fracture Healing $5,121,514
University of California, San Diego Alysson Muotri Early Translational IV A drug-screening platform for autism spectrum disorders using human astrocytes $1,656,456
Gladstone Institutes, J. David Steven Finkbeiner Early Translational IV Development of Novel Autophagy Inducers to Block the Progression of and Treat Amyotrophic Lateral Sclerosis (ALS) and Other Neurodegenerative Diseases $2,049,053
Stanford University Julien Sage Conference 3rd International RB conference $10,000
University of California, San Francisco Peter Stock Conference IPITA 2013 - 14th World Congress of the International Pancreas and Islet transplant Association $10,000
OCTANe Foundation for Innovation Matthew Jenusaitis Conference Orange County Summit on Regenerative Medicine (OCSRM) $2,500
University of California, San Diego Joan Heller Brown Conference International Society for Heart Research (ISHR) XX1 World Congress $10,000
Sangamo BioSciences, Inc. Fyodor Urnov Strategic Partnership II A Treatment For Beta-thalassemia via High-Efficiency Targeted Genome Editing of Hematopoietic Stem Cells $2,760,540
Cedars-Sinai Medical Center Barry Stripp Research Leadership Epithelial progenitors and the stromal niche as therapeutic targets in lung disease $4,841,830
Stanford University Hiromitsu Nakauchi Research Leadership Generation of functional cells and organs from iPSCs $5,426,135
University of California, San Diego Eric Ahrens Research Leadership Molecular Imaging for Stem Cell Science and Clinical Application $5,680,474

Pages

Icon for XLSX export